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background
 
Information on the clinical features of the severe acute respiratory syndrome (SARS)
will be of value to physicians caring for patients suspected of having this disorder. 
 
methods
 
We abstracted data on the clinical presentation and course of disease in 10 epidemio-
logically linked Chinese patients (5 men and 5 women 38 to 72 years old) in whom SARS
was diagnosed between February 22, 2003, and March 22, 2003, at our hospitals in Hong
Kong, China. 
 
results
 
Exposure between the source patient and subsequent patients ranged from minimal
to that between patient and health care provider. The incubation period ranged from
2 to 11 days. All patients presented with fever (temperature, >38°C for over 24 hours),
and most presented with rigor, dry cough, dyspnea, malaise, headache, and hypoxemia.
Physical examination of the chest revealed crackles and percussion dullness. Lym-
phopenia was observed in nine patients, and most patients had mildly elevated amino-
transferase levels but normal serum creatinine levels. Serial chest radiographs showed
progressive air-space disease. Two patients died of progressive respiratory failure; his-
tologic analysis of their lungs showed diffuse alveolar damage. There was no evidence
of infection by 
 
Mycoplasma pneumoniae, Chlamydia pneumoniae,
 
 or 
 
Legionella pneumophila.
 
 All
patients received corticosteroid and ribavirin therapy a mean (
 
±
 
SD) of 9.6
 
±
 
5.42 days after
the onset of symptoms, and eight were treated earlier with a combination of beta-lac-
tams and macrolide for 4
 
±
 
1.9 days, with no clinical or radiologic efficacy.
 
conclusions
 
SARS appears to be infectious in origin. Fever followed by rapidly progressive respira-
tory compromise is the key complex of signs and symptoms from which the syndrome
derives its name. The microbiologic origins of SARS remain unclear.
abstract
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n the fall of 2002, there were reports
 
from Guangdong Province in southern China
of 305 cases of highly contagious and very
severe atypical pneumonia of unknown cause. The
condition appeared to be particularly prevalent
among health care workers and their household
members; many cases were rapidly fatal.
 
1
 
 On March
13, 2003, as the condition began to spread from
China, the World Health Organization (WHO) is-
sued a global alert about the outbreak and institut-
ed worldwide surveillance. In March the U.S. Cen-
ters for Disease Control and Prevention (CDC)
termed this condition the severe acute respiratory
syndrome (SARS) and provided a clinical case def-
inition.
 
2
 
 Herein we report the clinical, radiologic,
and laboratory features of 10 of our patients with
SARS whose cases were epidemiologically linked.
Since the microbiology of these cases remains un-
resolved, we provide the clinical and epidemiologic
information for use in case recognition and man-
agement.
 
patients
 
Between February 22 and March 22, 2003, we iden-
tified 10 epidemiologically linked patients (all south-
ern Chinese) whose disease met the CDC case defi-
nition of March 17, 2003, of SARS at our hospital
cluster (Queen Mary Hospital, Kwong Wah Hos-
pital, and Pamela Youde Nethersole Eastern Hospi-
tal) in Hong Kong (Table 1).
 
2
 
 Patients were inter-
viewed to ascertain their possible contacts with each
other, as noted in Figure 1. 
 
radiologic assessment
 
The chest radiographs of 10 patients were evalu-
ated without reference to clinical details. Volumetric
contrast-enhanced computed tomography (CT)
with high-resolution CT scanning of the thorax was
available in three patients (Patients 3, 4, and 10), and
these were also reviewed. The pattern of opacifi-
cation was categorized as air space (ground-glass
opacification, focal consolidation, lobar consolida-
tion, or patchy consolidation), interstitial (reticular),
or diffuse (affecting all lung zones). The presence of
pleural effusions was also noted. 
 
microbiologic evaluation 
 
Respiratory secretions (sputum in all patients and
tracheal aspirate and bronchoalveolar-lavage fluid
in Patients 1, 2, and 3) were analyzed for convention-
al bacteria (with blood, chocolate, and MacConkey
agars), 
 
Legionella pneumophila
 
 (with BCYE
 
a
 
 medi-
um), and mycobacteria (with LJ medium). Gram-
stained and auramine-rhodamine–stained smears
were examined to search for bacterial or acid-fast
morphotypes. 
Single or, when available, paired serum samples
were tested for 
 
Mycoplasma pneumoniae
 
 (Serodia-
Myco-II, Fujirebio) and 
 
Chlamydia pneumoniae
 
 and
 
C. psittaci
 
 (MRL microimmunofluorescence kit). Uri-
nary antigen detection (Binax Now test kits, Binax)
was performed for 
 
L. pneumophila
 
 and pneumococ-
cus. Immunofluorescence techniques were used to
detect antigens in nasopharyngeal aspirates (and
bronchoalveolar-lavage fluid in Patient 1) with com-
mercially available reagents from Dako Diagnostics
and Chemicon International.
 
patients and contact history
 
The mean (
 
±
 
SD) age of the 10 patients (5 men and
5 women) was 52.5
 
±
 
11.0 years (median, 49.5; range,
35 to 72). Except as noted below, all of the patients
had unremarkable medical histories. Patient 2 had
stable hypertension and benign prostatic hyper-
trophy, Patient 4 had ischemic heart disease and
non-insulin-dependent diabetes mellitus, and Pa-
tient 10 had non-insulin-dependent diabetes and
resected renal-cell carcinoma of the right kidney.
Patient 2 was taking metoprolol and nifedipine; Pa-
tient 4 was taking aspirin, diltiazem, and metfor-
min; and Patient 10 was taking gliclazide and met-
formin. Eight of the 10 patients had never smoked,
1 was a current smoker (25 cigarettes per day), and
1 was a former smoker (20 cigarettes per day) who
had stopped five years earlier.
The contact history among the patients in this
cluster is shown in Figure 1A. Patient 1, who had the
first known case of SARS in Hong Kong, was a ne-
phrologist working in a hospital in southern China
who had traveled to Hong Kong on February 21,
2003, having first had symptoms five days earlier.
On arrival in Hong Kong he felt well enough to
sightsee and shop with his brother-in-law, but the
next day he sought urgent care and was directly ad-
mitted to the intensive care unit (ICU) of Hospital
A with respiratory failure. Patient 2, a Hong Kong
resident, was the brother-in-law of Patient 1 and
had had social contact with Patient 1 for 10 hours
while sightseeing and shopping. Patient 3 was a
nurse in the accident and emergency department
i
methods
results
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* Plus–minus values are means ±SD. A plus sign indicates that the sign or symptom was present, and a minus sign that it was absent. Normal 
ranges are as follows: for hemoglobin, 13 to 18 g per deciliter; for the leukocyte count, 4¬10
 
9
 
 to 11¬10
 
9
 
 per liter; for the lymphocyte count, 
1.5¬10
 
9
 
 to 4¬10
 
9
 
 per liter; for the platelet count, 150¬10
 
9
 
 to 400¬10
 
9
 
 per liter; for alanine aminotransferase (ALT), 6 to 53 U per liter; for aspar-
tate aminotransferase (AST), 13 to 33 U per liter; for creatinine, 82 to 106 µmol per liter; for the partial pressure of carbon dioxide (PaCO
 
2
 
), 
4.7 to 6.0 kPa; and for the partial pressure of oxygen (PaO
 
2
 
), 12 to 17 kPa. To convert values for creatinine to milligrams per deciliter, divide by 
88.4. NA denotes not available.
† Data were available for seven patients.
 
‡ Data were available for five patients.
 
Table 1. Characteristics of the Patients on Presentation.*
Patient No. Summary
 
1 2 3 4 5 6 7 8 9 10
Sex M M F M F F F F M M —
Age (yr) 64 53 35 72 56 38 47 54 50 56 52.5±11.0
Smoking history Never Never Never Never Never Never Never Never Current Former
Symptoms
Cough + ¡ + + + + + + + ¡ 8+
Sputum production ¡ ¡ ¡ ¡ ¡ + ¡ ¡ ¡ ¡ 1+
Dyspnea + + ¡ + ¡ + + + ¡ ¡ 6+
Pleurisy + ¡ + ¡ ¡ + ¡ ¡ ¡ ¡ 3+
Sore throat ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ ¡ —
Rhinorrhea ¡ ¡ ¡ ¡ ¡ + ¡ ¡ ¡ ¡ 1+
Malaise + + ¡ ¡ ¡ + + + + + 7+
Myalgia + + ¡ ¡ ¡ + + ¡ + ¡ 5+
Rigor + + + + + + + + + ¡ 9+
Fever (temperature >38°C 
for 24 hr)
+ + + + + + + + + + 10+
Headache + + + ¡ ¡ + + + + ¡ 7+
Physical signs
Crackles + + + + + + ¡ + + + 9+
Percussion dullness + + + + + ¡ ¡ ¡ + + 7+
Hemoglobin (g/dl) 13.7 13.7 11.4 13.5 14.3 11.6 13.3 11.4 14.2 11.6 12.9±1.22
Leukocyte count (¬10
 
¡9
 
/liter) 12.2 11.4 3.6 8.6 9.3 5.6 6.1 5.2 3.2 5.9 7.1±3.1
Lymphocyte count (¬10
 
¡9
 
/liter) 1.2 1.6 0.8 0.6 1.4 0.4 0.9 0.6 1.3 0.6 0.9±0.4
Platelet count (¬10
 
¡9
 
/liter) 239 160 134 245 309 170 235 115 161 354 212.2±77.8
ALT (U/liter) 62 48 16 21 63 20 198 14 58 78 57.8±54.4
AST (U/liter) 84 67 35 51 62 — — — 96 103 71.1±24.5†
Creatinine (µmol/liter) 77 84 80 115 81 69 57 66 103 148 88.0±27.1
PaCO
 
2
 
 on room air (kPa) 3.51 4.4 NA 4.8 3.4 NA NA NA 3.8 NA 4.0±0.6
PaO
 
2
 
 on room air (kPa) 6.7 8.3 NA 7.0 10.2 NA NA NA 11.9 NA 8.8±2.2‡
Oxygen saturation on room air 
(%)
60 91 97 80 94 94 96 93 96 99 90±11.8‡
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Figure 1. Contact History (Panel A) and Temporal Relation between Contact and the Onset of Symptoms (Panel B) in the 10 Patients with SARS.
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of Hospital A who was present in the same resus-
citation room but at least 1 m away from Patient 1,
who was being treated by another team of physi-
cians and nurses. Patient 3 had no direct contact
with Patient 1 and was wearing a surgical mask at
the time. Patient 5 was a health care assistant who
worked in the ICU of Hospital A and had unprotect-
ed hospital contact (without a mask or gown) with
Patient 2 for six hours. 
Patient 4 was a Chinese-Canadian businessman
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who had returned to Hong Kong for a family re-
union on February 13, 2003. He had not traveled
outside Toronto for more than 12 months before
his return to Hong Kong. His stay at Hotel X over-
lapped with that of Patient 1 for one day. There was
no known direct contact between Patient 1 and Pa-
tient 4. Patient 4 could not recollect whether he
had seen Patient 1 in the common areas of the hotel.
Patients 6, 7, and 8 were nurses who worked at Hos-
pital B, where Patient 4 was admitted and remained
for six days for treatment of pneumonia before he
was transferred to Hospital C. During this period,
the nurses spent five eight-hour shifts stationed
on the general ward on which Patient 4 was hospi-
talized. The three nurses recalled a close encoun-
ter with Patient 4 during which they cleaned him
when he had fecal incontinence after an episode
of diarrhea on March 3, 2003. The nurses did not
wear masks or gowns during their routine nursing
care of any patients on the ward. Patient 9 was the
nephew of Patient 4 and visited him once at Hotel
X, once at Hospital B, and once in the ICU of Hos-
pital C, each time for 10 minutes. At the last of these
visits, Patient 4 was receiving noninvasive positive-
pressure ventilation. Patient 10 stayed in the same
cubicle (with six beds) on the same ward of Hos-
pital B as Patient 4 for a total of five days while re-
covering uneventfully from a total nephrectomy for
a resectable right renal-cell carcinoma. Another bed
separated them from one another. There was no
social or other contact between the two patients,
who were both largely bedridden. Apart from these
contacts, and with the exception of Patient 1, none
of the patients had any known contacts with any-
one with respiratory illness or had traveled to south-
ern China, Vietnam, or Singapore for at least three
months. 
Figure 1B shows the temporal relation between
contact and the onset of symptoms in the 10 pa-
tients. The incubation period, calculated as the num-
ber of days between likely exposure and the onset
of symptoms,
 
3
 
 could be precisely determined only
for Patients 2, 3, 4, and 5 (two, two, six, and two
days, respectively), since the other patients had mul-
tiple contacts with the source patients. The ranges
of possible incubation periods were 1 to 6, 5 to 11,
5 to 11, 1 to 5, and 2 to 7 days for Patients 6, 7, 8, 9,
and 10, respectively.
 
clinical and other features 
 
All 10 patients presented with fever (temperature,
>38°C for more than 24 hours), and all but 1 also
had rigor (Table 1). There was a median interval of
five days (range, three to seven) from the onset of
fever to the occurrence of dyspnea. All patients re-
mained febrile until the initiation of empirical treat-
ment with corticosteroids and ribavirin. Over half
the patients also reported a nonproductive cough,
dyspnea, malaise, and headache on presentation.
On physical examination of the chest, crackles and
dullness on percussion were detected in most pa-
tients. The results of cardiovascular, abdominal, and
neurologic examination were normal in all patients
given their known preexisting conditions. Mild leu-
kocytosis and leukopenia were each observed in two
patients at initial presentation. Lymphopenia (less
than 1500 cells per cubic millimeter) was observed
in nine patients; clinically significant thrombocy-
topenia (less than 50,000 platelets per cubic milli-
meter) was not observed. The aspartate aminotrans-
ferase level, alanine aminotransferase level, or both
were elevated slightly (to less than four times the
upper limit of the reference range in seven patients);
serum creatinine levels were normal in eight pa-
tients. Five patients presented with hypoxemia, and
three (Patients 4, 6, and 8) had infrequent diarrhea
in the first three days after the onset of fever. The
onset of diarrhea could not be attributed to antibi-
otic therapy in Patients 6 and 8, since they had not
received such treatment before its onset. 
 
microbiologic assessment 
 
The sputum culture yielded only commensal spe-
cies (Table 2). Acid-fast staining of all respiratory
secretions was negative in each patient. Examina-
tion of nasopharyngeal aspirates for rapid viral an-
tigen detection of influenzavirus A and B, parainflu-
enzavirus 1, 2, and 3, respiratory syncytial virus, and
adenovirus was negative. The serologic titers of
 
C. pneumoniae, C. psittaci,
 
 and 
 
M. pneumoniae
 
 showed
no significant increase over a period of 7 to 10 days
in the entire cohort. Urinary antigen detection for
 
L. pneumophila
 
 and pneumococcus was negative in
all cases. At this time, the microbiologic origin of
SARS was unknown.
 
radiologic assessment 
 
All patients except Patient 2 had abnormal chest
radiographs on presentation. The primary abnor-
mality on the initial chest radiograph was air-space
shadowing: ground-glass opacities (in Patients 4, 5,
and 10), focal consolidation (in Patients 3 and 9),
or patchy consolidation (Patients 6, 7, and 8) (Fig.
2A). No interstitial pattern was found on the chest
radiographs. Opacities were predominantly in the
lower lung zones in eight patients (Patients 2, 3,
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5, 6, 7, 8, 9, and 10) and in upper zones in one (Pa-
tient 4). None of the patients had pleural effusions. 
The air-space opacities increased in size, extent,
and severity in seven patients (Patients 3, 4, 5, 6,
7, 9, and 10) within the first 10 days after admis-
sion. The chest radiograph of Patient 1 did not show
clinically significant changes from presentation
to death; a diffuse miliary nodulation was noted
throughout. In Patient 2, the chest radiograph re-
mained unremarkable for more than a week, after
which diffuse opacification appeared (Fig. 2B); a
similar course was observed in Patient 5. Among
the survivors, six patients (Patients 3, 4, 6, 8, 9, and
10) had some improvement of the air-space opaci-
ties, with variable residual reticular opacities, with-
in two weeks after presentation. 
Predominant abnormalities found on initial CT
scans were subpleural focal consolidation with air
bronchograms and ground-glass opacities. These
occurred mostly, but not exclusively, in the poste-
rior aspects of the lower lobes (Fig. 2C). No pleural
effusions, mediastinal nodes, or central pulmo-
nary emboli were found. 
 
treatment and outcome
 
All of the patients were treated empirically with cor-
ticosteroids and ribavirin, as noted below. Before
this combination was administered, all patients
except Patients 7 and 8 received a combination of
a beta-lactam (Augmentin, Rocephin, or Maxipime)
and a macrolide (clarithromycin or azithromycin)
for a mean (and median) of four days (range, two
to six), which had no effect on the overall clinical
course, fever, or radiographically evident profusion
of disease (Table 2 and Fig. 2 and 3). Empirical treat-
ment consisted of a combination of intravenous ri-
bavirin (8 mg per kilogram of body weight every
eight hours) or oral ribavirin (1.2 g every eight hours,
in Patient 4 only) and intravenous corticosteroids
(hydrocortisone at a dose of 4 mg per kilogram ev-
ery eight hours tapered to 200 mg every eight hours
or methylprednisolone at a dose of 240 to 320 mg
daily) in all patients (Fig. 3). There was a mean of
9.6
 
±
 
5.42 days (median, 12.5; range, 3 to 22) be-
tween the onset of symptoms and treatment with
the combination of corticosteroids and ribavirin.
Figure 3 shows the response in temperature, heart
rate, oxygen saturation, and total leukocyte, lympho-
cyte, and platelet counts after the beginning of ther-
apy. There was resolution of fever and improvement
in heart rate within the first two days of starting
treatment. There was also an increasing trend to-
ward improved lymphocyte and platelet counts after
eight days of treatment. 
In Patients 1 and 2 there was a steady deteriora-
tion in gas exchange despite an increase in ventilato-
ry support from noninvasive support to intubation
and mechanical pressure-controlled ventilation with
 
* C denotes commensals, AFB acid-fast bacilli, NPA nasopharyngeal aspirate for rapid viral antigen detection, NA not available, and ND not done.
 
Table 2. Results of Microbiologic Assessment in 10 Patients with SARS.*
Patient No. Sputum Culture Sputum AFB Smear NPA Serologic Analysis Urinary Antigen Detection
 
C. pneumoniae C. psittaci M. pneumoniae S. pneumoniae L. pneumophila
 
1 C — — <1:32 <1:32 <1:40 ND ND
2 C — — <1:32 <1:32 <1:40 ND ND
3 C — — <1:32 <1:32 <1:40 ND ND
4 C NA NA <1:32 <1:32 <1:40 — —
5 C — — <1:32 <1:32 <1:40 ND ND
6 C — — 1:32 <1:32 <1:40 — —
7 C — — <1:32 <1:32 <1:40 — —
8 C — — <1:32 1:32 <1:40 — —
9 C — — 1:32 <1:32 <1:40 — —
10 C NA NA 1:128 <1:32 <1:40 — —
Copyright © 2003 Massachusetts Medical Society. All rights reserved. 
Downloaded from www.nejm.org at UNIVERSITY OF HONG KONG on November 7, 2006 . 
 n engl j med 
 
348;20
 
www.nejm.org may 
 
15, 2003
 
a cluster of cases of sars in hong kong
 
1983
 
high positive end-expiratory pressures and a fraction
of inspired oxygen of 1.0. Despite intensive physio-
logical support, both patients died. Postmortem ex-
amination of the lungs of Patient 1 revealed marked
alveolar edema with foci of hemorrhage and hyaline
membrane formation. There was desquamation of
pneumocytes, but there were few free inflamma-
tory cells, either polymorphonuclear or mononu-
clear cells in the alveolar spaces. There were scat-
tered foci of alveolar myxoid fibroblastic tissue, a
finding consistent with the early organization phase
of progressive pneumonia. Interalveolar septa were
mildly thickened, with a mild mononuclear infil-
trate. There was no tissue necrosis, viral inclusions,
fungi, or bacteria on the sections. These features
were considered to reflect severe diffuse alveolar
damage. Patient 2 underwent a biopsy by video-
assisted thoracoscopy on day 5 that showed only
mild diffuse alveolar damage. 
From the onset of disease to the time of this writ-
ing, only Patient 3 has had a complete clinical re-
covery (no supplementary oxygen as of day 12) and
radiographic recovery (resolution of right-lower-
lobe consolidation on day 18), leading to her dis-
charge on day 20. This patient has continued to have
nonspecific malaise, even on day 26. From the onset
of symptoms, Patients 4 through 10 have been un-
well for 23.1
 
±
 
5.5 days (median, 25.5; range, 18 to
33) and have had a partial radiologic and clinical
recovery. Only Patients 4, 7, and 9 are still oxygen-
dependent; the mean oxygen saturation was 95.1
 
±
 
2.6 percent (median, 96; range, 90 to 99) in the
eight survivors. Patient 3 recovered completely and
had no exercise restriction, whereas Patients 4, 7,
and 9 were able to walk only three to five steps on
the level, and Patients 5, 6, 8, and 10 were able to
walk on the level without apparent restriction, with-
in the confines of the isolation wards. Patients 4, 6,
7, 8, and 9 still reported dry cough, which was con-
sidered subjectively to be milder than that experi-
enced at the onset of disease. None of the surviving
patients reported any of the other symptoms listed
in Table 2.
Our experience with these 10 epidemiologically
linked patients confirms that SARS is a contagious
and rapidly progressive infectious disease that can
affect otherwise healthy persons, sometimes after
even trivial contacts. It is not known why some per-
sons (such as the wife of Patient 4, who stayed in
the same hotel room with him throughout) re-
main asymptomatic despite substantial exposure. 
SARS presents predominantly with high fever
(temperature, >38°C for more than 24 hours) and
discussion
 
Figure 2. Chest Radiographs of Patient 6 (Panel A), 
Showing Patchy Consolidation in the Right Lower Zone 
(Arrows), and Patient 2 (Panel B), Showing Diffuse Involve-
ment of All Lung Zones in Both Lungs, and a High-Reso-
lution CT Scan of Patient 4 (Panel C), Showing Subpleural 
Areas of Consolidation and Ground-Glass Opacification 
with Air Bronchogram (Arrow) Affecting the Posterior 
Aspects of the Lungs, Particularly the Lower Lobes.
A
B
C
Copyright © 2003 Massachusetts Medical Society. All rights reserved. 
Downloaded from www.nejm.org at UNIVERSITY OF HONG KONG on November 7, 2006 . 
 n engl j med 
 
348;20
 
www.nejm.org may 
 
15
 
, 
 
2003
 
The
 
 new england journal 
 
of
 
 medicine
 
1984
 
Figure 3. Response to Treatment with an Intravenous Corticosteroid and Ribavirin for the 10 Patients with SARS.
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rigor, followed by dry cough, which may in some
cases proceed rapidly to respiratory failure, accom-
panied by radiographic evidence of air-space dis-
ease. The incubation period in our patients was be-
tween 1 and 11 days, and in most of our clear-cut
cases, the patients presented 2 days after exposure.
Our experience therefore singles out at-risk expo-
sure (however trivial) to source patients and fever
as the most important pointers to the diagnosis of
SARS. Indeed, the finding that many people whose
condition meets the CDC case definition
 
2
 
 of SARS
do not have respiratory failure.
 
4
 
 Although there
was no clinical response to combined therapy with
a beta-lactam and a macrolide, empirical treat-
ment with a combination of a high-dose cortico-
steroid and ribavirin coincided with clinical im-
provement. Most patients appeared to have clinical
and radiographic improvement, although the full
time course of the illness is not known. It is also of
note that the two patients who died did not have
multiorgan failure, as is often the case with patients
with the acute respiratory distress syndrome.
The primary radiologic appearance of SARS is
air-space shadowing determined on CT to be sub-
pleural focal consolidation with air bronchograms
and ground-glass opacities predominantly affect-
ing the lower lobes. The initial radiographic appear-
ance, however, may be normal. Air-space opacifica-
tion progresses within a few days of presentation,
increasing in size, extent, and severity. In some cas-
es, there is further progression to diffuse opacifica-
tion suggestive of the acute respiratory distress syn-
drome. Resolution of air-space shadowing occurs
with features suggesting that the disease is entering
a fibrotic phase. Radiographically, SARS may be in-
distinguishable from bacterial bronchopneumonia
or viral infections, and more important, it shares
CT features with other conditions that result in
subpleural air-space disease, such as bronchiolitis
obliterans with organizing pneumonia and acute
interstitial pneumonia.
 
5-7
 
 In the later stages, partic-
ularly with diffuse involvement of the lungs, the
radiographic appearance is similar to that of the
acute respiratory distress syndrome. 
The clinical and radiographic features of the
disease in our patients and, in particular, its high-
ly contagious nature strongly point to a viral cause
of SARS. Most patients with SARS had the onset of
symptoms two to five days after exposure to the re-
spective source patients. Such a short incubation
period argues against infection with 
 
M. pneumoniae
 
or 
 
C. pneumoniae.
 
 For 
 
M. pneumoniae,
 
 the reported
incubation period ranges from 6 to 32 days, with
a median of 14 days.
 
3
 
 The incubation period for
 
C. pneumoniae
 
 is unclear but appears to be long, with
estimates ranging from 10 to 30 days.
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L. pneumo-
phila
 
 is not known to be transmitted from human
to human and is thus most unlikely to be the causa-
tive agent. Our microbiologic tests also showed
no evidence of infection by these agents. Research
to identify potential viral infective agents in SARS
is ongoing. 
Given the information we present on case trans-
mission, it is important to take appropriate isolation
precautions with patients suspected to have SARS.
Information on current recommendations can be
found at http://www.who.int/csr/sars/guidelines
and http://www.cdc.gov/ncidod/sars/ic.htm. Be-
cause the disease has appeared in many health care
workers, they should have a high index of suspi-
cion when fever and features suggestive of SARS
develop in them or their family members. In such
cases, we believe that health care workers should
present themselves for evaluation, to avoid putting
others at risk. When the microbiology of SARS is
more fully understood, better methods of case
identification should follow.
 
We are indebted to Ms. Christina Yan, June Sun, and Christine So
for technical assistance and to all the medical and nursing staff
members who assisted in the care of these patients.
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